Compare ECOR & INUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ECOR | INUV |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.0M | 47.2M |
| IPO Year | 2018 | 1996 |
| Metric | ECOR | INUV |
|---|---|---|
| Price | $6.10 | $2.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $22.00 | $12.67 |
| AVG Volume (30 Days) | 46.9K | ★ 339.2K |
| Earning Date | 01-01-0001 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.51 | 50.00 |
| EPS | N/A | ★ N/A |
| Revenue | $25,182,000.00 | ★ $86,209,305.00 |
| Revenue This Year | $28.92 | $12.82 |
| Revenue Next Year | $32.50 | $4.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 57.09 | 2.88 |
| 52 Week Low | $4.16 | $0.28 |
| 52 Week High | $9.22 | $6.27 |
| Indicator | ECOR | INUV |
|---|---|---|
| Relative Strength Index (RSI) | 42.70 | 51.61 |
| Support Level | $4.64 | $2.39 |
| Resistance Level | $8.02 | $3.64 |
| Average True Range (ATR) | 0.71 | 0.34 |
| MACD | -0.16 | 0.03 |
| Stochastic Oscillator | 5.42 | 43.35 |
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.